| Identification | |
| Name: | AFN 941 |
| Synonyms: | (9S,10R,11R,13R)-2,3,10,11,12,13,15,16,17,18-Decahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one;1,2,3,4-Tetrahydro Staurosporine;AFN 941 |
| CAS: | 220038-19-7 |
| Molecular Formula: | C28H30N4O3 |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C28H30N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h5,7,9,11,17,20,26,29H,4,6,8,10,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | 398.9°C |
| Boiling Point: | 735.9°C at 760 mmHg |
| Density: | 1.57g/cm3 |
| Refractive index: | 1.809 |
| Flash Point: | 398.9°C |
| Usage: | Staurosporine derivative for use as isoenzyme PKCa inhibitors and anticancer agents |
| Safety Data | |
 |
|
